Example: Heart Attack

Clinical Trials Sponsored by Faron Pharmaceuticals Ltd

Total 4 results

NCT03733990

Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients

Conditions: Cancer
NCT03119701

Terminated

Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA

Conditions: Preventive Medicine; Multi Organ Failure
NCT02622724

Terminated

Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS)

Conditions: Respiratory Distress Syndrome, Adult
NCT00789685

Completed

Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II

Conditions: Acute Lung Injury; Acute Respiratory Distress Syndrome